An Interview with Dr. Harbour, leading uveal melanoma research expert

*Don’t forget to register for our first ever annual STEPS FOR SIGHT Challenge! Register yourself and your team at the link below:

https://www.charityfootprints.com/sight/eventdetails

DEADLINE TO REGISTER YOURSELF/YOUR TEAM is JAN 15! Don't wait! We start tracking our 7K steps a day on Jan 1-31!! Take steps toward a cure with us! 

A Cure in Sight is joined by Dr. Harbour in an interview “from the vault” that we wanted to bring back to you this month as a special gift!

J. William Harbour, M.D., is an American ophthalmologist, ocular oncologist and cancer researcher. He is currently Chair of the Department of Ophthalmology at the University of Texas Southwestern Medical Center in Dallas. He previously served as the Vice Chair and Director of Ocular Oncology at the Bascom Palmer Eye Institute and the Associate Director for Basic Science at the Sylvester Comprehensive Cancer Center of the University of Miami Miller School of Medicine. His clinical practice focuses on intraocular tumors, including uveal (ocular) melanoma, retinoblastoma, lymphoma and other neoplasms. His field of research includes the genetics and genomics of cancer, with a focus on prognostic biomarkers, mechanisms of metastasis, and molecular targeted therapies. He has given over 300 invited scientific lectures, and published over 200 peer-reviewed scientific articles and book chapters. Dr. Harbour founded the Ocular Oncology Service at the Washington University School of Medicine in St. Louis, where he was the Paul A. Cibis Distinguished Professor of Ophthalmology & Visual Sciences. (source from Wikipedia)

In this interview, he covers topics such as PRAME, what it means, how testing was developed; as well as other genetic markers he and his research teams have developed testing for. He explains the development of the collaborative oncology group, a team a many doctors that he is encouraging to come together to pool their research and bring as many resources to the table in studying the micro metastasis of uveal melanoma. Eye treatment he says is not the primary issue anymore; we can treat the eye. It’s the rest of the body, particularly spread to the liver or lungs or other areas of the body that are the most concerning.

He discusses early detection strategies and research, and answers a host of other questions you may have as a patient newly diagnosed with ocular melanoma, or if you just want a good solid update. More news to come in 2022 with our future online seminars!

***Saturday Dec 11 we have our second annual JINGLE MINGLE! Be sure to register at the link below!

www.tinyurl.com/wwaf5wwt

************************

Be sure to follow us on Instagram @acureinsight, for more stories, tips, and ideas to help you navigate this journey with OM!

 

*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more! Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure. LINK TO PAYPAL OR VENMO 

This podcast was hosted by Danet Peterson and produced by Agora Media.